Jonathan Mizrahi, William Senapedis, Charles O'Donnell, J. Graeme Hodgson, Joseph V. Newman, Stephen Siecinski, Chia-Chi Lin. "First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.4_suppl.606